Update in cancer chemotherapy: genitourinary tract cancer, Part 1. (Q39691214)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3323538%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

review article

1 reference

title

Update in cancer chemotherapy: genitourinary tract cancer, Part 1 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3323538%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

author name string

J C Wright

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3323538%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

publication date

1 December 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3323538%20AND%20SRC:MED&resulttype=core&format=json

Journal of the National Medical Association

22 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3323538%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3323538%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3323538%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

1249-1258

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3323538%20AND%20SRC:MED&resulttype=core&format=json

Extension of renal cell carcinoma into the vena cava: the rationale for aggressive surgical management

22 September 2019

cites work

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Diagnosis and management of renal cell carcinomaA clinical and pathologic study of 309 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

The Value of Radiotherapy in the Treatment of Hypernephroma-a Clinical Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Proceedings: Carcinoma of the kidney

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Proceedings: Chemotherapy of adenocarcinoma of the kidney

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Proceedings: Hormone-induced and spontaneous regression of metastatic renal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Proceedings: Cancer of the kidney--natural history and staging

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Renal Cell Carcinoma: Natural History and Chemotherapeutic Experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Immunotherapy of disseminated renal cell carcinoma with transfer factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Current status of the therapy of advanced renal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Immune RNA therapy for renal cell carcinoma: survival and immunologic monitoring

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Chemotherapy and genitourinary oncology. I. Bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Renal cancer invading the inferior vena cava: clinical review and anatomical approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Specific immunotherapy of advanced renal carcinoma: Evidence for the polyclonality of metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

In Vivo and In Vitro Effects of Xenogeneic Immune Ribonucleic Acid in Patients With Advanced Renal Cell Carcinoma: A Phase I Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Cytoreductive surgery and systemic bacillus Calmette-Guerin therapy in metastatic renal cancer: a phase II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Renal cell carcinoma: antitumor effects of leukocyte interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Active specific immunotherapy with supportive measures in the treatment of advanced palliatively nephrectomised renal adenocarcinoma. A controlled clinical study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Angioinfarction plus nephrectomy for metastatic renal cell carcinoma--an update

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Phase II study of alpha interferon on renal cell carcinoma. Summary of three collaborative trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Magnetic resonance imaging of Wilms tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Aggressive treatment of metastatic renal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Renal tumors: pathology and prognosis in 295 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

New growths of the kidney and ureter

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Malignant neoplasms of the kidney; an analysis of 353 patients followed five years or more.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Radical nephrectomy for renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

HORMONES AND THE KIDNEY: POSSIBLE THERAPEUTIC ROLE OF TESTOSTERONE IN A PATIENT WITH REGRESSION OF METASTASES FROM RENAL ADENOCARCINOMA.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

The place of radiotherapy in the management of parenchymal carcinoma of the kidney.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Surgery for Metastatic Renal Cell Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

The Place of Irradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Medroxyprogesterone acetate in the treatment of renal cell carcinoma (hypernephroma).

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Prognostic Significance of Renal Vein Invasion by Hypernephroma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

The results of radical nephrectomy for renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Post-operative irradiation in the treatment of renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Renal cell carcinoma.Natural history and results of treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Renal Adenocarcinoma: 28-year Review, with Emphasis on Rationale and Feasibility of Preoperative Radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

The results of radical nephrectomy for renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Prognosis in renal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Effect of tumor vaccines in immunizing patients with cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Hormonal therapy in advanced renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

An immunological approach to the therapy of cancer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Adjuvant Therapy for Adenocarcinoma of the Kidney: Present Position and Prospects1

1 reference

https://pubmed.ncbi.nlm.nih.gov/3323538

12 December 2020

Identifiers

1 reference